In Battle for Real Estate, a Disordered Protein Wins Out

15/06/2017

In Battle for Real Estate, a Disordered Protein Wins Out New TSRI Study Points to Potential Strategy to Kill Cancer Cells

LA JOLLA, CA March 8, 2017 Research findings that first had scientists scratching their heads have turned out to be quite revolutionary, according to study leaders at The Scripps Research Institute (TSRI).

The scientists found that in a competition between two apparently equivalent proteins, one protein wins out every time as it swoops in to claim a cellular binding target. This protein is of special interest to researchers because it can trigger cancer cells to kill themselves. In fact, the researchers now hope future therapeutics that mimic this protein may work as potential cancer drugs.

This work at the molecular level has a real potential to benefit patients, said TSRI Research Associate Rebecca Berlow, first author of the new study, published online today in the journal Nature.

A Puzzling Finding

Human cells, including cancer cells, can activate a set of genes that enable them to go into survival mode when deprived of an oxygen-carrying blood supply. This mode switches on when a protein called HIF-1 binds to a part, called TAZ1, of a second protein, called CBP.

Cells have an off switch too. To turn off the hypoxic response to low oxygen, a protein called CITED2 jumps in to bind to TAZ1 when oxygen levels go back to normal.

As intrinsically disordered proteins (IDPs), neither HIF-1 nor CITED2 folds into a stable shape by itself; instead, these domains remain unstructured, ready to change conformations to wedge themselves into the right binding site on TAZ1.

HIF-1 and CITED2 have an equal affinity for TAZ1, and scientists didn't expect one to bind more effectively than the other. So TSRI Research Associate Rebecca Berlow was surprised to discover that, when forced to compete, CITED2 pushes HIF-1 out of the way every time.

This finding totally violated everything we know about equilibrium, said Berlow. My first reaction was how did I mess this up?'

CITED2's behavior seemed to contradict a tenet of thermodynamics that states that a system should become less ordered, not more organized over time. Obviously, something else was going on but what?

Puzzled, Berlow presented her findings to TSRI Professor Peter Wright, Cecil H. and Ida M. Green Investigator at TSRI, and study co-author TSRI Professor Jane Dyson. They decided to investigate further. If the initial finding was correct, Wright realized, this would be quite revolutionary.

CITED2 Has a Hidden Superpower

Berlow's initial findings weren't wrong in fact, they revealed a new phenomenon in protein competition.

The researchers found that the system is not randomly becoming more organized. Rather, CITED2 appears to be the first example of a protein that uses its disordered shape, not its binding affinity, to win out.

Discovering CITED2's ability to win these battles is a paradigm shift, said Wright, senior author of the new study.

Taking on Cancer

This finding could have implications for future cancer drugs. The researchers explained that past drug candidates have tried to interrupt the cancer cell survival mode by stopping HIF-1 from ever reaching TAZ1, but they haven't been very effective. The new study suggests that it may be more efficient to mimic nature's own response and use a CITED2-like drug to knock HIF-1 away.

This is a very, very efficient switch, said Wright. You only need a small amount of CITED2 to switch off the hypoxic response, and no amount of HIF-1 can switch it back on.

Next, the researchers plan to study the detailed mechanisms that allow CITED2 to take over the TAZ1 binding site. They are also looking into the therapeutic potential of CITED2 in other diseases where HIF-1 can intensify a dangerous low-oxygen response.

The study, Hypersensitive termination of the hypoxic response by a disordered protein switch, was supported by the National Institutes of Health (grant CA096865), the Skaggs Institute for Chemical Biology and a postdoctoral fellowship from the American Cancer Society (grant 125343-PF-13-202-01-DMC).

About The Scripps Research Institute

The Scripps Research Institute (TSRI) is one of the worlds largest independent, not-for-profit organizations focusing on research in the biomedical sciences. TSRI is internationally recognized for its contributions to science and health, including its role in laying the foundation for new treatments for cancer, rheumatoid arthritis, hemophilia, and other diseases. An institution that evolved from the Scripps Metabolic Clinic founded by philanthropist Ellen Browning Scripps in 1924, the institute now employs more than 2,500 people on its campuses in La Jolla, CA, and Jupiter, FL, where its renowned scientists including two Nobel laureates and 20 members of the National Academies of Science, Engineering or Medicine work toward their next discoveries. The institutes graduate program, which awards PhD degrees in biology and chemistry, ranks among the top ten of its kind in the nation. In October 2016, TSRI announced a strategic affiliation with the California Institute for Biomedical Research (Calibr), representing a renewed commitment to the discovery and development of new medicines to address unmet medical needs. For more information, see www.scripps.edu.

# # #

For information:

Office of Communications

Tel: 858-784-2666

Fax: 858-784-8118

press@scripps.edu

LINK:	http://www.scripps.edu/news/press/2017/20170308wright.html...
	See more stories from scripps

Most recent headlines

05/01/2027

Worlds first 802.15.4ab-UWB chip verified by Calterah and Rohde & Schwarz to be demoed at CES 2026

Worlds first 802.15.4ab-UWB chip verified by Calterah and Rohde & Schwarz to be ...

01/06/2026

Dolby Sets the New Standard for Premium Entertainment at CES 2026

January 6 2026, 05:30 (PST) Dolby Sets the New Standard for Premium Entertainment at CES 2026 Throughout the week, Dolby brings to life the latest innovatio...

02/05/2026

Dalet Flex LTS Delivers Smarter Search, Faster Editing, and an AI-Ready Foundation for Modern Media

Dalet, a leading technology and service provider for media-rich organizations, t...

01/05/2026

NBCUniversal's Peacock to Be First Streamer to Integrate Dolby's Full Suite of Premium Picture and Sound Innovations

January 5 2026, 18:30 (PST) NBCUniversal's Peacock to Be First Streamer to ...

01/04/2026

DOLBY AND DOUYIN EMPOWER THE NEXT GENERATON OF CREATORS WITH DOLBY VISION

January 4 2026, 18:00 (PST) DOLBY AND DOUYIN EMPOWER THE NEXT GENERATON OF CREATORS WITH DOLBY VISION Douyin Users Can Now Create And Share Videos With Stun...

18/03/2026

Net Insight Names Larissa GrnerMeeus CPO

Newly named chief product officer (CPO), Larissa G rner Meeus will return to Net Insight on May 4. Larissa G rner Meeus will become CPO of Net Insight on May 4...

18/03/2026

SVG Europe's The Football Summit 2026: Select Sessions Now Available to Watch on SVG PLAY

SVG Europe's The Football Summit 2026 explored how the sports broadcasting i...

18/03/2026

SVG's SportsTech@NABShow Blog Goes Live as Countdown to Vegas Heats Up

The 2026 NAB Show kicks off one month from today and SVG is once again set to cover the show from every angle. SVG's SportsTech@NAB Show Blog is now live - ...

18/03/2026

The Premiere of Dead Lover Showcases Grave Robbing and Sex With a Giant Finger

(L-R) The cast and crew of Dead Lover at The Ray Theater for its premiere at the 2025 Sundance Film Festival. (Photo by Robin Marshall/Shutterstock for Sundan...

18/03/2026

Music Row Piano from Wiltone Productions

Yamaha C7 captured in Nashville Wiltone Productions have announced the release of Music Row Piano, a deeply sampled Yamaha C7 piano library that's been ...

18/03/2026

Techivation introduce T-Warmer Mk2

Bass-enhancement plug-in upgraded Along with a steady stream of new releases, Techivation have recently been revisiting some of the older plug-ins in their ...

18/03/2026

Tonal Balance Control 3 from iZotope

Mix-reference plug-in overhauled iZotope's powerful mix-referencing plug-in has just reached its third major version, and now boasts a new capture proce...

18/03/2026

Toontrack Transistor Organ EKX

Latest EZKeys 2 expansion arrives Toontrack's staggering collection of EZKeys 2 expansions has grown once again, and the latest instalment delivers a on...

18/03/2026

Jess Ho explores the politics of food in new SBS Audio podcast For The Culture

Jess Ho explores the politics of food in new SBS Audio podcast For The Culture 18 March, 2026 Media releases New SBS Audio podcast For The Culture, hosted ...

18/03/2026

Future-ready broadcasts with ATSC 3.0 and enhanced services from Rohde & Schwarz at NAB 2026

Future-ready broadcasts with ATSC 3.0 and enhanced services from Rohde & Schwarz...

18/03/2026

LCTWS 2026

London Calling - When The Industry Convened to Help Streaming Find its MoJo In this blog, Laura Rognoni reflects on key discussions from the Connected TV World...

18/03/2026

SMPTE Unveils 2026 NAB Show Educational Presentations

SMPTE Unveils 2026 NAB Show Educational Presentations Brie Clayton March 18, 2026 0 Comments SMPTE , the home of media professionals, technologists, a...

18/03/2026

Auditel Ad Campaign Shot on Blackmagic PYXIS 12K

Auditel Ad Campaign Shot on Blackmagic PYXIS 12K Brie Clayton March 18, 2026 0 Comments LED wall virtual production blends 12K open gate acquisition w...

18/03/2026